Adherence to and Gastrointestinal Tolerability of Monthly Oral or Quarterly Intravenous Ibandronate Therapy in Women with Previous Intolerance to Oral Bisphosphonates: A 12-Month, Open-Label, Prospective Evaluation - Concepedia

Concepedia

Publication | Closed Access

Adherence to and Gastrointestinal Tolerability of Monthly Oral or Quarterly Intravenous Ibandronate Therapy in Women with Previous Intolerance to Oral Bisphosphonates: A 12-Month, Open-Label, Prospective Evaluation

38

Citations

29

References

2008

Year

E. Michael Lewiecki, Ann M. Babbitt, Veronica Piziak, Zafer E. Ozturk, Henry G. Bone

Clinical Therapeutics

Previous IntoleranceMonthly OralOral MedicineOral BisphosphonatesMedicineOsteoporosisAnesthesiology

References

	Year	Citations

Page 1